These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36081507)

  • 1. Chronic granulomatous disease and McLeod syndrome: Stem cell transplant and transfusion support in a 2-year-old patient-a case report.
    Helander L; McKinney C; Kelly K; Mack S; Sanders M; Gurley J; Dumont LJ; Annen K
    Front Immunol; 2022; 13():994321. PubMed ID: 36081507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Granulomatous Disease with the McLeod Phenotype: a French National Retrospective Case Series.
    Lhomme F; Peyrard T; Babinet J; Abou-Chahla W; Durieu I; Moshous D; Neven B; Rohrlich PS; Albinni S; Amiranoff D; Dumont MD; Lortholary O; Héritier S; Marguet C; Suarez F; Fischer A; Blanche S; Hermine O; Mahlaoui N
    J Clin Immunol; 2020 Jul; 40(5):752-762. PubMed ID: 32562208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.
    Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J;
    J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km.
    Bansal I; Jeon HR; Hui SR; Calhoun BW; Manning DW; Kelly TJ; Lee S; Baron BW
    Vox Sang; 2008 Apr; 94(3):216-220. PubMed ID: 18167163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first successful bone marrow transplantation in Vietnam for a young Vietnamese boy with chronic granulomatous disease: a case report.
    Nguyen-Thanh B; Nguyen-Ngoc-Quynh L; Dang-Thi H; Le-Quynh C; Nguyen-Thi-Van A; Thuc-Thanh H; Dang-Anh D; Lee PP; Cao-Viet T; Tran-Minh D
    Front Immunol; 2023; 14():1134852. PubMed ID: 37153592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopreservation of rare pediatric red blood cells for support following bone marrow transplant.
    Kelly K; Helander L; Hazegh K; Stanley C; Moss R; Mack S; Sanders ML; Gurley J; McKinney C; Dumont LJ; Annen K
    Transfusion; 2022 May; 62(5):954-960. PubMed ID: 35403731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How we approach transfusions in a patient with high risk of alloimmunization from McLeod phenotype.
    Addams J; Hasan RA; Saifee NH
    Pediatr Blood Cancer; 2023 Feb; 70(2):e30119. PubMed ID: 36495235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease.
    Nagler A; Ackerstein A; Kapelushnik J; Or R; Naparstek E; Slavin S
    Bone Marrow Transplant; 1999 Aug; 24(3):339-42. PubMed ID: 10455377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment.
    Åhlin A; Fugeläng J; de Boer M; Ringden O; Fasth A; Winiarski J
    Acta Paediatr; 2013 Nov; 102(11):1087-94. PubMed ID: 23937637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in a child with X-linked chronic granulomatous disease: A first report in Asia.
    Janjindamai C; Manuyakorn W; Anurathapan U; Pakakasama S; Wattanasirichaigoon D; Kamchaisatian W; Benjaponpitak S; Hongeng S
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):278-282. PubMed ID: 31677618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers.
    Tsilifis C; Torppa T; Williams EJ; Albert MH; Hauck F; Soncini E; Kang E; Malech H; Schuetz C; von Bernuth H; Slatter MA; Gennery AR
    J Clin Immunol; 2023 Nov; 43(8):1964-1973. PubMed ID: 37620741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
    Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
    Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation.
    Cole T; Pearce MS; Cant AJ; Cale CM; Goldblatt D; Gennery AR
    J Allergy Clin Immunol; 2013 Nov; 132(5):1150-5. PubMed ID: 23870668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease.
    Bhatt ST; Schulz G; Hente M; Slater A; Murray L; Shenoy S; Bednarski JJ
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28030. PubMed ID: 31599480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
    Seger RA; Gungor T; Belohradsky BH; Blanche S; Bordigoni P; Di Bartolomeo P; Flood T; Landais P; Müller S; Ozsahin H; Passwell JH; Porta F; Slavin S; Wulffraat N; Zintl F; Nagler A; Cant A; Fischer A
    Blood; 2002 Dec; 100(13):4344-50. PubMed ID: 12393596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of chronic granulomatous disease - Conventional treatment vs stem cell transplantation.
    Dedieu C; Albert MH; Mahlaoui N; Hauck F; Hedrich C; Baumann U; Warnatz K; Roesler J; Speckmann C; Schulte J; Fischer A; Blanche S; von Bernuth H; Kühl JS
    Pediatr Allergy Immunol; 2021 Apr; 32(3):576-585. PubMed ID: 33118209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.
    Chiriaco M; Salfa I; Di Matteo G; Rossi P; Finocchi A
    Pediatr Allergy Immunol; 2016 May; 27(3):242-53. PubMed ID: 26680691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation.
    Suzuki N; Hatakeyama N; Yamamoto M; Mizue N; Kuroiwa Y; Yoda M; Takahashi J; Tani Y; Tsutsumi H
    Int J Hematol; 2007 Jan; 85(1):70-2. PubMed ID: 17261504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma.
    Robertson K; Couban S; Leddin D; Ahmad I; Connors L
    Allergy Asthma Clin Immunol; 2018; 14():17. PubMed ID: 29755533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.